Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
19
TOVX Quote, Financials, Valuation and Earnings
Last price:
$0.19
Seasonality move
:
18281.59%
Day range:
$0.18 - $0.20
52-week range:
$0.17 - $2.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.33x
P/B ratio:
1.02x
Volume:
6.6M
Avg. volume:
2.7M
1-year change:
-83.08%
Market cap:
$6.8M
Revenue:
--
EPS (TTM):
-$5.54
Earnings Data
Next earnings date for TOVX
--
Most recent earnings per share
-$0.45
Missed by $0.07
(Sep 30/2025)
Consensus Estimate
-$0.38
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TOVX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$0.37 | -- |
| 09/30/2025 | Q3 | -- | -- | -$0.45 | -$0.38 | -$0.07 |
| 08/14/2025 | Q2 | -- | -- | -$1.93 | -$0.47 | -$1.46 |
| 05/13/2025 | Q1 | -- | -- | -$1.55 | -$1.56 | $0.01 |
| 03/06/2025 | Q4 | -- | -- | -$1.60 | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$6.81 | -$5.25 | -$1.56 |
| 08/13/2024 | Q2 | -- | -- | -$10.72 | -- | -- |
| 05/07/2024 | Q1 | -- | -- | -$7.53 | -$8.50 | $0.97 |
| 03/25/2024 | Q4 | -- | -- | -$8.00 | -$8.25 | $0.25 |
| 11/13/2023 | Q3 | -- | -- | -$4.85 | -$8.50 | $3.65 |
| 08/11/2023 | Q2 | -- | -- | -$8.38 | -- | -- |
| 05/16/2023 | Q1 | -- | -- | -$7.40 | -- | -- |
| 03/16/2023 | Q4 | -- | -- | -$8.89 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$7.62 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$7.07 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$7.73 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$9.97 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$6.20 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$6.05 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$31.55 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$36.21 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$34.62 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$45.12 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$50.17 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$46.74 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$78.15 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$56.32 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$63.41 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$277.41 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$232.17 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$289.01 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$161.61 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $175.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$1,225.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$262.50 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$175.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$175.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$787.50 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$875.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1,050.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$1,050.00 | -- | -- |
Theriva Biologics, Inc. Earnings Questions
-
How Much did Theriva Biologics, Inc. Generate in Revenue Last Quarter?
Theriva Biologics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Theriva Biologics, Inc. Beat Earnings Last Quarter?
Theriva Biologics, Inc. announced earnings per share of -$0.45 which represents a miss of analyst forecast a -$0.38 per share.
-
Is Theriva Biologics, Inc. Profitable?
Theriva Biologics, Inc. reported -$28K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Theriva Biologics, Inc. EPS Next Year?
Theriva Biologics, Inc.'s earnings are forecast to decrease from -$19.03 per share to -$2.15 per share next year representing a decrease of -88.7%.
-
When is Theriva Biologics, Inc.'s Earnings Date?
Currently, Theriva Biologics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
